Breakthrough CAR-T cell therapy communication

In the highly competitive CAR T-cell R&D landscape it is important to cut through the clutter with your message.

​

The Malaghan Institute, in partnership with Wellington Zhaotai Therapies is currently developing a 3rd generation CAR T-cell therapy, improving CAR T-cell therapies and extending them to other cancers.

​

We helped them to create a compelling scientific narrative to communicate the unique benefits of their novel CAR T-cell therapies with a range of stakeholders.